Localization of a negative glucocorticoid response element of the human corticotropin releasing hormone gene

Molecular and Cellular Endocrinology

Volumn 127, Issue 2, 1997, Pages 189-199

  Malkoski, Stephen P ^a   Handanos, Christine M ^a   Dorin, Richard I ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

cAMP response element; Corticotropin releasing hormone; Gene expression; Glucocorticoid receptor; Glucocorticoid response element; Glucocorticoids; Luciferase

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; DEXAMETHASONE; DNA BINDING PROTEIN; GLUCOCORTICOID;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA SEQUENCE; DNA TRANSFECTION; ELECTROPHORETIC MOBILITY; HORMONAL REGULATION; HORMONE RESPONSIVE ELEMENT; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; TRANSCRIPTION REGULATION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; BINDING, COMPETITIVE; CELL LINE; CHORIONIC GONADOTROPIN; CONSENSUS SEQUENCE; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DEXAMETHASONE; DNA; GLUCOCORTICOIDS; HUMANS; MAMMARY TUMOR VIRUS, MOUSE; PITUITARY GLAND, ANTERIOR; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, GLUCOCORTICOID; RECOMBINANT FUSION PROTEINS; SEQUENCE DELETION; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

EID: 0030991780     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(96)04004-X     Document Type: Article

References (54)

1. Antoni, F.A. (1986) Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr. Rev. 7,351.
2. Muglia, L., Jacobson, L., Dikkes, P. and Majzoub, J.A. (1995) Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 373, 427.
3. Kovacs, K.J. and Mezey, E. (1987) Dexamethasone inhibits corticotropin-releasing factor gene expression in the rat paraventricular nucleus. Neuroendocrinology 46, 365.
4. Kovacs, K., Kiss, J.Z. and Makara, G.B. (1986) Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy. Neuroendocrinology 44, 229.
5. Jingami, H., Matsukura, S., Numa, S. and Imura, H. (1985) Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/β-lipotropin precursor mRNA in the pituitary in rats. Endocrinology 117, 1314.
6. Roche, P.J., Crawford, R.J., Fernley, R.T., Tregear, G.W. and Coghlan, J.P. (1988) Nucleotide sequence of the gene coding for ovine corticotropin- releasing factor and regulation of its mRNA levels by glucocorticoids. Gene 71, 421.
7. Drouin, J., Charron, J., Gagner, J.P., Jeannotte, L., Nemer, M., Plante, R.K. and Wrange, O. (1987) Pro-opiomelanocortin gene: a model for negative regulation of transcription by glucocorticoids. J. Cell. Biochem. 35, 293.
8. Majzoub, J.A., Emanuel, R., Adler, G., Martinez, C., Robinson, B. and Wittert, G. (1993) Second messenger regulation of mRNA for corticotropin-releasing factor. Ciba Found. Symp. 172, 30.
9. Van, L.P., Spengler, D.H. and Holsboer, F. (1990) Glucocorticoid repression of 3′,5′-cyclic-adenosine monophosphate-dependent human corticotropin-releasing-hormone gene promoter activity in a transfected mouse anterior pituitary cell line. Endocrinology 127, 1412.
10. Guardiola-Diaz, H.B., Kolinske, J.S., Gates, L.H. and Seasholtz, A.F. (1996) Negative glucocorticoid regulation of cyclic adenosine 3′,5′-monophosphate-stimulated corticotropin-releasing hormone-reporter expression in AtT-20 cells. Mol. Endocrinol. 10, 317.
11. Frim, D.M., Robinson, E.G., Pasieka, K.B. and Majzoub, J.A. (1990) Differential regulation of corticotropin-releasing hormone mRNA in rat brain. Am. J. Physiol. 258, E686.
12. Robinson, B.G., Emanuel, R.L., Frim, D.M. and Majzoub, J.A. (1988) Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc. Natl. Acad. Sci. USA 85, 5244.
13. Imaki, T., Nahan, J.L., Rivier, C., Sawchenko, P.E. and Vale, W. (1991) Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J. Neurosci. 11, 585.
14. Vamvakopoulos, N.C. and Chrousos, G.P. (1994) Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. Endocr. Rev. 15, 409.
15. Bastian, L.S. and Nordeen, S.K. (1991) Concerted stimulation of transcription by glucocorticoid receptors and basal transcription factors: limited transcriptional synergism suggests mediation by coactivators/adaptors. Mol. Endocrinol. 5, 619.
16. Chatterjee, V.K., Madison, L.D., Mayo, S. and Jameson, J.L. (1991) Repression of the human glycoprotein hormone α-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators. Mol. Endocrinol. 5, 100.
17. Shibahara, S., Morimoto, Y., Furutani, Y., Notake, M., Takahashi, H., Shimizu, S., Horikawa, S. and Numa, S. (1983) Isolation and sequence analysis of the human corticotropinreleasing factor precursor gene. EMBO J. 2, 775.
18. Maxwell, I.H, Harrison, G.S., Wood, W.M. and Maxwell, F. (1989) A DNA casette containing a trimerized SV40 polyadenylation signal which efficiently blocks spurious plasmid-initiated transcription. Biotechniques 7, 276.
19. Nordeen, S.K. (1988) Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6, 454.
20. Kay, T.W.H. and Jameson, J.L. (1992) Identification of a Gonadotropin-Releasing Hormone-Responsive Region in the Glycoprotein Hormone a-Subunit Promoter. Mol. Endocrinol. 6, 1767.
21. Giguere, V., Hollenberg, S.M., Rosenfeld, M.G. and Evans, R.M. (1986) Functional domains of the human glucocorticoid receptor. Cell 46, 645.
22. Hollenberg, S.M., Giguere, V., Segul, P. and Evans, R.M. (1987) Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell 49, 39.
23. Williams, T.M., Burlein, J.E., Ogden, S., Kricka, L.J. and Kant, J.A. (1989) Advantages of firefly luciferase as a reporter gene: application to the interleukin-2 gene promoter. Anal. Biochem. 176, 28.
24. Freedman, L.P. and Alroy, I. (1993) Gel mobility shift assay to study nuclear hormone receptor-DNA interactions. Methods Mol. Genet. 1, 280.
25. Vanderbilt, J.N., Miesfeld, R., Maler, B.A. and Yamamoto, K.R. (1987) Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol. Endocrinol. 1, 68.
26. Deutsch, P.J., Hoeffler, J.P., Jameson, J.L., Lin, J. and Haberner, J.F. (1988) Structural determinants for transcriptional activation by cAMP-responsive DNA elements. J. Biol. Chem. 263, 184466.
27. Seasholtz, A.F., Thompson, R.C. and Douglass, J.O. (1988) Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene. Mol. Endocrinol. 2, 1311.
28. Spengler, D., Rupprecht, R., Van, L.P. and Holsboer, F. (1992) Identification and characterization of a 3′,5′-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter. Mol. Endocrinol. 6, 1931.
29. Diamond, M.I., Miner, J.N., Yoshinaga, S.K. and Yamamoto, K.R. (1990) Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249, 1266.
30. Freedman, L.P., Luisi, B.F., Korszun, Z.R., Basavappa, R., Sigler, P.B. and Yamamoto, K.A. (1988) The function and structure of the metal coordination sites within the glucocorticoid receptor DNA-binding domain. Nature 334, 543.
31. Stauber, C., Altschmied, J., Akerblom, I.E., Marron, J. L. and Mellon, P.L. (1992) Mutual cross-interference between glucocorticoid receptor and CREB inhibits transactivation in placental cells. New Biologist 4, 527.
32. Gomez, M.T., Magiakou, M.A., Mastorakos, G. and Chrousos, G.P. (1993) The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndrome. J. Clin. Endocrinol. Metab. 77, 173.
33. Muglia, L., Jacobson, L., Luedke, C. and Majzoub, J.A. (1995) Regulation of the hypothalamic-pituitary-adrenal axis in corticotropin-releasing hormone deficient mice [Abstract 585]. 77th Annu. Meeting of The Endocrine Society.
34. Adler, G.K., Smas, C.M. and Majzoub, J.A. (1988) Expression and dexamethasone regulation of the human corticotropin-releasing hormone gene in a mouse anterior pituitary cell line. J. Biol. Chem. 263, 5846.
35. Dorin, R.I., Takahashi, H., Nakai, Y., Fukata, J., Naitoh, Y. and Imura, H. (1989) Regulation of human corticotropin-releasing hormone gene expression by 3′,5′-cyclic adenosine monophosphate in a transformed mouse corticotroph cell line. Mol. Endocrinol. 3, 1537.
36. Sawchenko, P.E. (1987) Adrenalectomy-induced enhancement of CRF and vasopressin immunoreactivity in parvocellular neurosecretory neurons: anatomic, peptide, and steroid specificity. J. Neurosci. 7, 1093.
37. Adler, G.K., Smas, C.M., Fiandaca, M., Frim, D.M. and Majzoub, J.A. (1990) Regulated expression of the human corticotropin releasing hormone gene by cyclic AMP. Mol. Cell. Endocrinol. 70, 165.
38. Dorin, R.I., Zlock, D.W. and Kilpatrick, K. (1993) Transcriptional regulation of human corticotropin releasing factor gene expression by cyclic adenosine 3′,5′-monophosphate: differential effects at proximal and distal promoter elements. Mol. Cell. Endocrinol. 96, 99.
39. Rosen, L.B., Majzoub, J.A. and Adler, G.K. (1992) Effects of glucocorticoid on corticotropin-releasing hormone gene regulation by second messenger pathways in NPLC and AtT-20 cells. Endocrinology 130, 2237.
40. Reisine, T., Rougon, G., Barbet, J. and Affolter, H.U. (1985) Corticotropin-releasing factor-induced adrenocorticotropin hormone release and synthesis is blocked by incorporation of the inhibitor of cyclic AMP-dependent protein kinase into anterior pituitary tumor cells by liposomes. Proc. Natl. Acad. Sci. USA 82, 8261.
41. Hoeffler, J.P., Deutsch, P.J., Lin, J. and Haberner, J.F. (1989) Distinct cyclic AMP and phorbol ester-mediated signal transduction pathways converge at the level of transcriptional activation of DNA-binding proteins. Mol. Endocrinol. 3, 868.
42. Mugele, K., Kugler, H. and Spiess, J. (1993) Immortalization of a fetal rat brain cell line that expresses corticotropin-releasing factor mRNA. DNA Cell Biol. 12, 119.
43. Kushner, P.J., Baxter, J.D., Duncan, K.G., Lopez, G.N., Schaufele, F., Uht, R.M., Webb, P. and West, B.L. (1994) Eukaryotic regulatory elements linking in plasmid DNA: the activator protein-1 site in pUC. Mol. Endocrinol. 8, 405.
44. Jonat, C., Rahmsdorf, H.J., Park, K.K., Cato, A.C.B., Gebel, S., Ponta, H. and Herrlich, P. (1990) Antitumor promotion and anti-inflammation: down-modulation of AP-1 (fos/jun) activity by glucocorticoid hormone. Cell 62, 1189.
45. Jenab, S. and Inturrisi, C.E. (1995). Biochem. Biophys. Res. Comm. 210, 589.
46. Mordacq, J.C. and Linzer, D.I.H. (1989) Co-localization of elements required for phorbol ester stimulation and glucocoritcoid represssion of proliferin gene expression. Genes Dev. 3, 760.
47. Orti, E., Hu, L.M. and Munck, A. (1993) Kinetics of glucocorticoid receptor phosphorylation in intact cells. Evidence for hormone-induced hyperphosphorylation after activation and recycling of hyperphosphorylated receptors. J. Biol. Chem. 268, 7779.
48. Almof, T., Wright, A.P. and Gustafsson, J.A. (1995) Role of acidic and phosphorylated residues in gene activation by the glucocorticoid receptor. J. Biol. Chem. 270, 17535.
49. Mason, S.A. and Housley, P.R. (1993) Site-directed mutagenesis of the phosphorylation sites in the mouse glucocorticoid receptor. J. Biol. Chem. 268, 21501.
50. Moyer, M.L., Borror, K.C., Bona, B.J., DeFranco, D.B. and Nordeen, S.K. (1993) Modulation of cell signalling pathways can enhance or impair glucocorticoid-induced gene expression without altering the state of receptor phosphorylation. J. Biol. Chem. 268, 22933.
51. Beck, C.A., Weigel, N.L., Moyer, M.L. and Nordeen, S.K. (1993) The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc. Natl. Acad. Sci. USA 90, 4441.
52. Miner, J.N. and Yamamoto, K.R. (1991) Regulatory crosstalk at composite response elements. Trends Biochem. Sci. 16, 423.
53. Young, W.S., Mezey, E. and Siegel, R.E. (1986) Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci. Lett. 70, 198.
54. Yang-Yen, H.F., Chambard, J.C., Sun, Y.L., Smeal, T., Schmidt, T.J., Drouin, J. and Karin, M. (1990) Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62, 1205.